Allergan Inc
AGN
AGN was delisted on the 16th of March, 2015.
16 hedge funds and large institutions have $103M invested in Allergan Inc in 2016 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 2 reducing their positions, and 0 closing their positions.
645% more capital invested
Capital invested by funds: $13.9M → $103M (+$89.4M)
200% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 2
23% more funds holding
Funds holding: 13 → 16 (+3)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FIM
Frontier Investment Management
Dallas,
Texas
|
+$18.2M |
| 2 |
PCA
Peddock Capital Advisors
Braintree,
Massachusetts
|
+$1.49M |
| 3 |
FIM
Freedom Investment Management
Hartford,
Connecticut
|
+$1.1M |
| 4 |
NFGCM
Norman Fields Gottscho Capital Management
New York
|
+$420K |
| 5 |
GIM
Grassi Investment Management
Santa Clara,
California
|
+$259K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CI
Chartist Inc
Seal Beach,
California
|
-$34.1K |
| 2 |
BC
Bartlett & Co
Cincinnati,
Ohio
|
-$7.16K |
AGN Hedge Fund Activity: Q3 2016 in Review
16 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Allergan Inc (AGN) for Q3 2016, worth a combined $103M — up 645% from $13.9M a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new AGN positions and 0 closed out — a net gain of 3 holders — while 6 added to existing stakes and 2 trimmed.
The largest buyer was Frontier Investment Management, adding an estimated $18.2M. The largest seller was Chartist Inc, cutting an estimated $34.1K.
- 16 institutional investors held Allergan Inc (AGN) as of Q3 2016, up from 13 in Q2 2016.
- Funds reported $103M of Allergan Inc stock for Q3 2016, up 645% quarter-over-quarter.
- 3 funds opened new Allergan Inc positions in Q3 2016 and 0 closed out, a net change of +3 holders.
- The largest Allergan Inc buyer in Q3 2016 was Frontier Investment Management, an estimated $18.2M added.
- The largest Allergan Inc seller in Q3 2016 was Chartist Inc, an estimated $34.1K sold.
Based on aggregated 13F filings for Q3 2016.